跳至主要内容
临床试验/IRCT2014030716876N1
IRCT2014030716876N1已完成未知

The Effects of Rhus Coriaria L. (Sumac) on Serum Lipid Levels of Patients With Hyperlipidemia

Vice chancellor of Research, Shiraz University of Medical Sciences0 个研究点目标入组 74 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
74

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 65 years(—)
性别
All

入选标准

  • Age: 20-65 years old.
  • Serum triglyceride more than 150mg/dl and /or total cholesterol equal or more than 240mg/dl.
  • Exclusion criteria:
  • Serum triglyceride more than 500 mg/dl.
  • Serum LDL-cholesterol at level which need drug treatment according to the patient risk categories (NCEPATP III).
  • Diabetes mellitus.
  • Hypo or hyperthyroidism.
  • Any systemic illnesses e.g. liver cirrhosis, acute or chronic renal failure, heart failure.
  • Use of drugs: OCPs, lipid lowering agents, thiazides.
  • Pregnancy.
  • Alcoholism.
  • History of allergic reaction to Sumac.

排除标准

  • 未提供

研究者

发起方
Vice chancellor of Research, Shiraz University of Medical Sciences

相似试验

se of Sumac in treatment of hyperlipidemia | 临床试验